Latest News and Press Releases
Want to stay updated on the latest news?
-
Ensuring advanced cybersecurity protection for a tracking application based on GBT’s Long Range Radio SystemSAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCHD)...
-
Magna’s battery enclosures protect power sourceKey technology to enable electric vehiclesLightweight aluminum enclosure helps minimize battery mass AURORA, Ontario, Nov. 09, 2021 (GLOBE NEWSWIRE)...
-
LONDON and REDWOOD CITY, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology...
-
Grass Valley, CA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BrewBilt Manufacturing Inc. (the "Company") (OTCPINK: BBRW) announced today that the Company recorded revenues of...
-
NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf,...
-
ROCHESTER, N.Y., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative...
-
JERSEY CITY, New Jersey, Nov. 09, 2021 (GLOBE NEWSWIRE) -- InvestorWire -- Vision Hydrogen Corporation (OTCQB:VIHD) (the “Company”) announces the completion of the acquisition of VoltH2 Holdings AG...
-
VANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) ) announced today that our board of directors (the "Board") has approved a...
-
– SL-279252 (PD1-Fc-OX40L) demonstrates anti-tumor activity and evidence of dose-dependent immune activation in heavily pretreated, checkpoint experienced patients – – SL-172154 (SIRPα-Fc-CD40L)...
-
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing potentially first-in-class therapeutics that...